Scott B. Seibel
Pfizer
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Scott B. Seibel.
Bioorganic & Medicinal Chemistry Letters | 1997
John P. Dirlam; A. M. Belton; N.C. Birsner; R. R. Brooks; Shang-Poa Chang; R.Y. Chandrasekaran; J. Clancy; Brian J. Cronin; B. P. Dirlam; Steven M. Finegan; S. A. Froshauer; A.E. Girard; Shigeru F. Hayashi; R.J. Howe; J. C. Kane; Barbara J. Kamicker; S. A. Kaufman; Nicole L. Kolosko; M. A. Lemay; Robert Gerald Linde; J.P. Lyssikatos; C.P. MacLelland; Thomas V. Magee; M. A. Massa; S. A. Miller; Martha L. Minich; David Austen Perry; J.W. Petitpas; C.P. Reese; Scott B. Seibel
Abstract A 6a-(3′,4′-dichlorophenylamino) analog of viomycin was uncovered by a high-throughput screen against the animal health pathogen Pasteurella haemolytica, and has served as a novel lead structure for our infectious disease programs. We report herein the synthesis and activity of analogs of tuberactinomycins and capreomycin that are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci. This paper describes the synthesis and activity of some C-6a-substituted analogs of tuberactinomycins and capreomycin, which are active against Pasteurella spp., methicillin-resistant Staphylococcus aureus, and vancomycin-resistant enterococci.
Bioorganic & Medicinal Chemistry Letters | 2008
Subas M. Sakya; Andrei Shavnya; Hengmiao Cheng; Chao Li; Bryson Rast; Jin Li; David A. Koss; Burton H. Jaynes; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Michelle L. Haven; Michael P. Lynch
Structure-activity relationship (SAR) studies of novel 5-alkyl and 5-aryl/heteroaryl substituted 1,2,4-triazoles are described. The in vitro activity is compared to the pyrazole class of compounds with analogous side chains to delineate the contribution of the triazole ring nitrogen in binding to the active site. Both series are quite potent and selective in the canine whole blood (CWB) COX-2 assay, suggesting the increased binding contribution of the hydrophobic side chains.
Bioorganic & Medicinal Chemistry Letters | 1997
J.P. Lyssikatos; Shang-Poa Chang; J. Clancy; John P. Dirlam; Steven M. Finegan; A.E. Girard; Shigeru F. Hayashi; D.P. Larson; A.S. Lee; Robert Gerald Linde; C.P. MacLelland; J.W. Petitpas; Scott B. Seibel; C.B. Vu
Abstract This paper describes synthetic modifications of the C-19 position of tuberactinomycin B (viomycin) and related analogs. The in vitro antibacterial activity of selected analogs against Pasteurella multocida, Escherichia coli and methicillin-resistant Staphylococcus aureus is also discussed. Although C-19 arylation and thiolation did not improve antibacterial activity, C-19 benzyl carbamates, benzyl- and phenyl ureas were found to be more potent than the parent antibiotic.
Bioorganic & Medicinal Chemistry Letters | 2006
Subas M. Sakya; Kristin Lundy DeMello; Martha L. Minich; Bryson Rast; Andrei Shavnya; Robert J. Rafka; David A. Koss; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Lisa A. Lund; Suzanne H. St. Denis; Anne Hickman; Michelle L. Haven; Michael P. Lynch
Bioorganic & Medicinal Chemistry Letters | 2006
Hengmiao Cheng; Kristin Lundy DeMello; Jin Li; Subas M. Sakya; Kazuo Ando; Kiyoshi Kawamura; Tomoki Kato; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Rod Stevens; Lisa A. Lund; Donald W. Mann; Carolyn Rose Kilroy; Michelle L. Haven; Erik L. Nimz; Jason K. Dutra; Chao Li; Martha L. Minich; Nicole L. Kolosko; Carol F. Petras; Annette M. Silvia; Scott B. Seibel
Bioorganic & Medicinal Chemistry Letters | 2004
Jin Li; Kristin Lundy DeMello; Henry Cheng; Subas M. Sakya; Brian Scott Bronk; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Carolyn Rose Kilroy; Donald W. Mann; Eric L. Nimz; Michael P. Lynch; Michelle L. Haven; Nicole L. Kolosko; Martha L. Minich; Chao Li; Jason K. Dutra; Bryson Rast; Rhonda Marie Crosson; Barry James Morton; Glen W. Kirk; Kathleen M. Callaghan; David A. Koss; Andrei Shavnya; Lisa A. Lund; Scott B. Seibel; Carol F. Petras; Annette M. Silvia
The Journal of Antibiotics | 1997
Shigeru F. Hayashi; Laura J. L. Norcia; Scott B. Seibel; Annette M. Silvia
Bioorganic & Medicinal Chemistry Letters | 2007
Subas M. Sakya; Xinjun Hou; Martha L. Minich; Bryson Rast; Andrei Shavnya; Kristin Lundy DeMello; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Michelle L. Haven
Bioorganic & Medicinal Chemistry Letters | 2006
Subas M. Sakya; Hengmiao Cheng; Kristin Lundy DeMello; Andrei Shavnya; Martha L. Minich; Bryson Rast; Jason K. Dutra; Chao Li; Robert J. Rafka; David A. Koss; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Anne Hickman; Michelle L. Haven; Michael P. Lynch
The Journal of Antibiotics | 1998
Laura J. L. Norcia; Scott B. Seibel; Barbara J. Kamicker; Mary A. Lemay; Susan C. Lilley; Scott J. Hecker; Jay Bergeron; James A. Retsema; Shigeru F. Hayashi